Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and adolescents who have been diagnosed with acute lymphoblastic leukaemia (ALL) or Lymphoma, and who are being treated under the officially approved treatment plans for these conditions in Denmark
Who may not be able to join:
- Children and adolescents who do not meet the inclusion criteria listed above
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 004520224643
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with treatment-related impaired glucose tolerance; Number of participants with treatment-related diabetes; The extent of insulin resistance at baseline; The extent of insulin resistance at week 5; The extent of insulin resistance at week 8; The extent of insulin resistance at week 12/13; The extent of insulin resistance at week 15/16; The extent of insulin resistance at week 18/19; The extent of insulin resistance at week 20/21/22; The extent of insulin resistance at week 22/23/28; The extent of beta cell function at baseline; The extent of beta cell function at week 5;...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.